Systemic Rheumatoid Arthritis and Regenerative Medicine: The Immunomodulatory Potential of Umbilical Cord–Derived Mesenchymal Stem Cells
Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Autoimmune science Autoimmune science Rheumatoid arthritis is more than your joints. Can stem cells help? Why rheumatoid arthritis affects the whole body, how umbilical cord stem cells may help rebalance the immune system, and what trials show so far. 6 min readReviewed with the medical team of Stem Cells Colombia The 30-second version Rheumatoid arthritis is an immune system problem that can reach the heart, lungs, eyes and skin. Umbilical cord stem cells are studied to rebalance that immune response rather than switch it off. Trials using the cells alongside standard drugs have shown lower inflammation markers and better disease scores. If you live with rheumatoid arthritis, you know it is not just a joint problem. It shapes your mornings, your energy and your plans, and you want more good days. Here is what drives it, where today’s medicines leave room for more, and what umbilical cord stem cells are being studied for. Why is rheumatoid arthritis a whole-body disease? In rheumatoid arthritis the immune system mistakes the lining of your joints for an enemy. Immune cells move in, release inflammatory messengers such as TNF and IL-6, and the lining thickens and starts eating into cartilage and bone. Those messengers don’t stay in the joints. They circulate in the blood, which is why rheumatoid arthritis can also affect the heart and blood vessels, the lungs, the eyes and the skin, and why it drains your energy. It is a bit like a neighborhood argument that spills into the whole street. In plain wordsAutoimmune when the immune system attacks the body’s own tissues by mistake. Where do umbilical cord cells fit next to your medicines? Methotrexate, biologics and steroids have changed life for a great many people with rheumatoid arthritis. They work by turning down immune activity, and for many that is enough to keep the disease quiet. For people who want more control of their disease, researchers are studying ways to calm the attack while leaving the rest of the immune system free to do its job. That is where umbilical cord cells come in. Tip Never stop or change your rheumatoid arthritis medication on your own. Any change is a decision for your rheumatologist. What do stem cells do to the immune system? Mesenchymal stem cells are natural peacekeepers. In lab studies with cells from patients with rheumatoid arthritis, umbilical cord cells calmed overactive joint-lining cells and T cells and helped expand regulatory T cells, the immune system’s own brakes. In mice with arthritis, infusing the cells lowered inflammatory messengers and eased the disease. The key word is modulate. The aim is not to switch the immune system off but to help it find its balance again, turning down the part that is attacking you. Think of a mediator at a noisy meeting: nobody gets thrown out, but everyone lowers their voice. In plain wordsRegulatory T cells immune cells whose job is to calm other immune cells and keep friendly fire in check. What have trials in people found? In a Chinese phase I/II study, 64 people with rheumatoid arthritis received umbilical cord stem cells through a vein while continuing their usual medicines. At one and three years, blood markers of inflammation had fallen, disease activity and daily-function scores had improved, and routine safety tests stayed normal. A 2024 meta-analysis of randomized trials in several kinds of arthritis also points to a potential benefit in rheumatoid arthritis, with a good safety record. Research is growing, and larger controlled trials are building on these results. MythStem cells replace your arthritis medication. Reality: In the trials, cells were added to standard treatment. Your rheumatologist decides whether anything changes. What this means for you Keep your rheumatologist and your medication at the center of your care. If you want more control of your disease, ask for an evaluation of stem cells as an add-on. Bring recent labs, including inflammation markers, to any consultation; they show where you are starting from. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care The immune-calming effects of umbilical cord stem cells are well documented in the lab and in animal models of arthritis. In people, early-phase trials, mostly from China and used alongside standard drugs, report lower inflammation markers and better disease scores with a good safety record. A meta-analysis of randomized trials points the same way. Research is growing, and umbilical cord cells are a promising add-on to your care. The pathogenesis of rheumatoid arthritis · The New England Journal of Medicine, 2011 Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis · Arthritis Research & Therapy, 2010 Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study · Drug Design, Development and Therapy, 2019 Efficacy and safety of culture-expanded mesenchymal stromal cell therapy in the treatment of 4 types of inflammatory arthritis: A systematic review and meta-analysis of 36 randomized controlled trials · Seminars in Arthritis and Rheumatism, 2024 Bring your case How the doctors do it in Medellín Your protocol is led by a rheumatologist, Dr. Andrés Martínez, who reviews your diagnosis and recent labs with you by video and designs your plan with you before you
The Therapeutic Potential of Mesenchymal Stem Cells from Umbilical Cord for Systemic Treatment
Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Cell science Cell science Why stem cells through a vein? Systemic treatment, explained What umbilical cord mesenchymal stem cells are, why they are sometimes given through a vein, what they are studied for, and how safe they look. 5 min readReviewed with the medical team of Stem Cells Colombia The 30-second version Mesenchymal stem cells help mostly by releasing signals that calm inflammation and support repair. Given through a vein, they travel with your blood, so they suit conditions that affect the whole body. Dozens of trials show a good safety record, and research in autoimmune and inflammatory conditions is growing. Most people picture stem cell treatment as an application into a knee. That is one way to do it. The other way is a slow drip in a vein, and it is used when the problem isn’t in one place but everywhere your blood goes. Here is how that works, where the cells come from, what they are being studied for, and what the evidence says about safety. No lab coat required. What is a mesenchymal stem cell? Mesenchymal stem cells, or MSCs, live in many tissues and act as local repair managers. In the lab they can turn into bone, cartilage or fat cells. But in the body, most of their value comes from something else: they sense inflammation and damage, and respond by releasing a cocktail of helpful molecules. A well-known paper described them as an injury drugstore. They don’t fix the damage with their own hands. They hand out the right prescriptions to the cells around them: calm down, grow a new blood vessel, clean up here. In plain wordsImmunomodulation adjusting how strongly the immune system reacts, turning it down where it overreacts, without switching it off. Why umbilical cord cells? The stem cells come from the Wharton’s jelly, the soft cushioning tissue inside a donated umbilical cord, which is normally discarded after a birth. Collecting it involves no surgery for anyone. Reviews comparing sources describe umbilical cord cells as more primitive and faster-growing than cells from adult tissues, with strong immune-calming properties. They are also well tolerated when they come from a donor, so nothing has to be taken from you. Stem Cells Colombia doesn’t use cells from bone marrow or fat. In plain wordsWharton’s jelly the gel-like tissue that protects the blood vessels inside the umbilical cord; a rich source of young mesenchymal cells. When does a vein make more sense than a joint? If the problem is a worn knee, the cells go straight into the knee. But some conditions live in the immune system or the whole body, and no single injection point would reach them. Given through a vein, the cells and their signals circulate with your blood. Think of the difference between fixing one leaking pipe and adjusting the water pressure of the whole house. Systemic, intravenous protocols are being studied, and offered at Stem Cells Colombia, for: Autoimmune conditions, such as rheumatoid arthritis, lupus or multiple sclerosis, where the goal is to calm an immune system that attacks the body. Diabetes, where inflammation and immune activity play a role. Neurological conditions, reviewed first by a neurologist. Healthy aging, where the target is the chronic low-grade inflammation that builds with the years. For anything else, the specialists are open to reviewing any case. How safe is it? Safety is where the data are strongest. A 2020 analysis of 55 randomized trials, with nearly 2,700 patients who received mesenchymal cells through a vein, found a favorable safety profile, with no increase in infections, blood clots, cancer or deaths compared with the comparison groups; a short-lived fever was the only effect seen more often. Every intravenous protocol at Stem Cells Colombia starts with blood work and cancer markers, for your safety. MythDonor cells will be rejected like a transplanted organ. Reality: Mesenchymal cells are low in the markers that trigger rejection, which is why they can come from a donor without anti-rejection drugs. So does it work? It depends on the condition. For several autoimmune conditions, trials have shown encouraging results, and research is growing. A specialist reviews your case first and explains the evidence for your condition, with numbers, before you travel. What this means for you Ask whether your condition is best reached through a vein or with a local application. Ask what the evidence looks like for your condition specifically, not stem cells in general. Expect a safety screen before any intravenous protocol; it protects you. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care The safety of mesenchymal cells given through a vein is backed by many randomized trials and a large meta-analysis. Research is growing: several autoimmune and inflammatory conditions have encouraging early-phase trials, supported by lab and animal data. Reviews suggest umbilical cord cells have practical advantages over adult sources. The MSC: an injury drugstore · Cell Stem Cell, 2011 Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? · Tissue Engineering Part B: Reviews, 2014 Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis · EClinicalMedicine, 2020 Bring your case How the doctors do it in Medellín The intravenous